Molecular targets modulated by fangchinoline in tumor cells and preclinical models

© 2018 MDPI AG. All rights reserved. Despite tremendous progress made during the last few decades in the treatment options for cancer, compounds isolated from Mother Nature remain the mainstay for therapy of various malignancies. Fangchinoline, initially isolated from the dried root of Stephaniae te...

Full description

Bibliographic Details
Main Authors: Mérarchi, M., Sethi, G., Fan, L., Mishra, S., Arfuso, Frank, Ahn, K.
Format: Journal Article
Published: M D P I AG 2018
Online Access:http://hdl.handle.net/20.500.11937/72007
_version_ 1848762633760538624
author Mérarchi, M.
Sethi, G.
Fan, L.
Mishra, S.
Arfuso, Frank
Ahn, K.
author_facet Mérarchi, M.
Sethi, G.
Fan, L.
Mishra, S.
Arfuso, Frank
Ahn, K.
author_sort Mérarchi, M.
building Curtin Institutional Repository
collection Online Access
description © 2018 MDPI AG. All rights reserved. Despite tremendous progress made during the last few decades in the treatment options for cancer, compounds isolated from Mother Nature remain the mainstay for therapy of various malignancies. Fangchinoline, initially isolated from the dried root of Stephaniae tetrandrine, has been found to exhibit diverse pharmacological effects including significant anticancer activities both in tumor cell lines and selected preclinical models. This alkaloid appears to act by modulating the activation of various important oncogenic molecules involved in tumorigenesis leading to a significant decrease in aberrant proliferation, survival and metastasis of tumor cells. This mini-review briefly describes the potential effects of fangchinoline on important hallmarks of cancer and highlights the molecular targets modulated by this alkaloid in various tumor cell lines and preclinical models.
first_indexed 2025-11-14T10:50:40Z
format Journal Article
id curtin-20.500.11937-72007
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T10:50:40Z
publishDate 2018
publisher M D P I AG
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-720072020-12-03T03:52:46Z Molecular targets modulated by fangchinoline in tumor cells and preclinical models Mérarchi, M. Sethi, G. Fan, L. Mishra, S. Arfuso, Frank Ahn, K. © 2018 MDPI AG. All rights reserved. Despite tremendous progress made during the last few decades in the treatment options for cancer, compounds isolated from Mother Nature remain the mainstay for therapy of various malignancies. Fangchinoline, initially isolated from the dried root of Stephaniae tetrandrine, has been found to exhibit diverse pharmacological effects including significant anticancer activities both in tumor cell lines and selected preclinical models. This alkaloid appears to act by modulating the activation of various important oncogenic molecules involved in tumorigenesis leading to a significant decrease in aberrant proliferation, survival and metastasis of tumor cells. This mini-review briefly describes the potential effects of fangchinoline on important hallmarks of cancer and highlights the molecular targets modulated by this alkaloid in various tumor cell lines and preclinical models. 2018 Journal Article http://hdl.handle.net/20.500.11937/72007 10.3390/molecules23102538 http://creativecommons.org/licenses/by/4.0/ M D P I AG fulltext
spellingShingle Mérarchi, M.
Sethi, G.
Fan, L.
Mishra, S.
Arfuso, Frank
Ahn, K.
Molecular targets modulated by fangchinoline in tumor cells and preclinical models
title Molecular targets modulated by fangchinoline in tumor cells and preclinical models
title_full Molecular targets modulated by fangchinoline in tumor cells and preclinical models
title_fullStr Molecular targets modulated by fangchinoline in tumor cells and preclinical models
title_full_unstemmed Molecular targets modulated by fangchinoline in tumor cells and preclinical models
title_short Molecular targets modulated by fangchinoline in tumor cells and preclinical models
title_sort molecular targets modulated by fangchinoline in tumor cells and preclinical models
url http://hdl.handle.net/20.500.11937/72007